Optos plc founder bids to inspire others to follow in his award-winning footsteps

In 2000, Optos plc developed their first iteration of the retina scanner and started to offer a subscription service for professionals, making the imaging system affordable to use. By 2006 they had grown, with 1,000 systems out in the field, analysing over six million patients across three countries. In the same year Optos plc won the Royal Academy of Engineering MacRobert Award. By 2015, devices were...

MyWay Digital Health receives £1million award

Dundee University spin off company, MyWay Digital Health wins Digital Health Catalyst award of £1million from Innovate UK to develop a new artificial intelligence system to support clinicians and people with diabetes. The Innovate UK grant will be used to develop an artificial intelligence system that will give diabetes patients, and those treating them, automatic advice about their health.  MyDiabetesIQ will use data to predict whether...

SGS Introduces GMP DNA Sequencing Service at its Glasgow Laboratory

SGS, a leading bio/pharmaceutical, analytical and bio-analytical contract solutions provider, today announced that it is introducing a Sanger sequencing service at its Glasgow, UK, laboratory, to support genetic stability testing and perform identity testing on cell banks, plasmids, and viral seeds/vectors. The new service, which will be available under Good Manufacturing Practice (GMP) conditions, is supported by an investment in ABI Life Technologies’ validated 3500xl...

Funding boost brings lung imaging devices closer to clinic

£3.8million boost in funding will advance development of next generation medical devices that monitor disease deep inside the lungs. The funding has been awarded by the Engineering and Physical Sciences Research Council (EPSRC) to continue to support the research for the next five years. The investment will enable researchers to further develop systems that could revolutionise how lung diseases are investigated, diagnosed and treated. It...

TC BioPharm Teams up with Bluebird Bio to Develop Next Generation CAR T cells

Scottish biotech TC BioPharm enters into a collaboration and license agreement with bluebird bio (NASDAQ:BLUE) aimed at advancing the former’s CAR-engineered gamma delta T cell program into the clinic and expanding blood cancer and solid tumor targets. The collaboration teams up Bluebird bio, who are one of several companies working on safer versions of CAR-T cells and TC BioPharm who are developing CAR-T technology called ImmuniCAR which uses gene therapy to...

Breakthrough for Omega Diagnostics as CD4 Test Kit is Approved

Omega Diagnostic’s flagship HIV-management kit is now available for trade sales. The breakthrough came following successful performance evaluations in India and the UK. Omega will now enter the World Health Organisation (WHO) pre-qualification process. This takes around one year, and if successful, the group will be able to sell into larger NGO (non-governmental organisations) and UN procurement programmes. CD4 could have a major impact on...

Top